Erratum: Paper by Qian Y, Ma J, Guo X, Sun J, Yu Y, Cao B, Zhang L, Ding X, Huang J, Shao JF, entitled 'Curcumin Enhances the Radiosensitivity of U87 Cells by Inducing DUSP-2 Up-Regulation' [Cell Physiol Biochem 2015;35(4):1381-93. doi: 10.1159/000373959];Curcumin enhances the radiosensitivity of U87 cells by inducing DUSP-2 Up-regulation

Cellular Physiology and Biochemistry

Volumn 35, Issue 4, 2015, Pages 1381-1393

  Qian, Yu ^a   Ma, Jianfen ^a   Guo, Xiaoyi ^a   Sun, Jun ^a   Yu, Yongtao ^a   Cao, Boqiang ^a   Zhang, Lei ^a   Ding, Xiaopeng ^a   Huang, Jin ^a   Shao, Jun Fei ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Cell cycle; Curcumin; DUSP 2; Glioma; Radiosensitizer

Indexed keywords

5 ETHYNYL 2 DEOXYURIDINE; CURCUMIN; DUAL SPECIFICITY PHOSPHATASE 2; MITOGEN ACTIVATED PROTEIN KINASE; RADIOSENSITIZING AGENT; STRESS ACTIVATED PROTEIN KINASE; THYMIDINE DERIVATIVE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT;

APOPTOSIS; ARTICLE; CANCER RADIOTHERAPY; CELL COUNTING; CELL CYCLE REGULATION; CELL PROLIFERATION; CLONOGENIC ASSAY; COLONY FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; FLOW CYTOMETRY; G2 PHASE CELL CYCLE CHECKPOINT; GLIOBLASTOMA CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; M PHASE CELL CYCLE CHECKPOINT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RADIOSENSITIVITY; WESTERN BLOTTING; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; IONIZING RADIATION; METABOLISM; PHOSPHORYLATION; RADIATION DOSE; RADIATION RESPONSE; TUMOR CELL LINE; UPREGULATION;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CURCUMIN; DUAL SPECIFICITY PHOSPHATASE 2; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; G2 PHASE CELL CYCLE CHECKPOINTS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; M PHASE CELL CYCLE CHECKPOINTS; PHOSPHORYLATION; RADIATION TOLERANCE; RADIATION, IONIZING; UP-REGULATION;

EID: 84925432915     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000447791     Document Type: Erratum

References (28)

1. Ge YF, Sun J, Jin CJ, Cao B-Q, Jiang ZF, Shao JF: AntagomiR-27a targets FOXO3a in glioblastoma and 1 suppresses U87 cell growth in vitro and in vivo. Asian Pac J Cancer Prev 2013;14:963-968.
2. Siegel R, Naishadham D, Jemal A: Cancer statistics, 2012. CA Cancer J Clin 2012;62:10-29.
3. Pauwels B, Wouters A, Peeters M, Vermorken JB, Lardon F: Role of cell cycle perturbations in the combination therapy of chemotherapeutic agents and radiation. Future Oncol 2010;6:1485-1496.
4. Fernet M, Megnin-Chanet F, Hall J, Favaudon V: Control of the G2/M checkpoints after exposure to low doses of ionising radiation: Implications for hyper-radiosensitivity. DNA repair 2010;9:48-57.
5. Sharma RA, Gescher AJ, Steward WP: Curcumin: The story so far. Eur J Cancer 2005;41:1955-1968.
6. Holy JM: Curcumin disrupts mitotic spindle structure and induces micronucleation in MCF-7 breast cancer cells. Mutat Res 2002;518:71-84.
7. Shinojima N, Yokoyama T, Kondo Y, Kondo S: Roles of the Akt/mTOR/p70S6K and ERK1/2 signaling pathways in curcumin-induced autophagy. Autophagy 2007;3:635-637.
8. Wilken R, Veena MS, Wang MB, Srivatsan ES: Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol Cancer 2011;10:12.
9. Jagetia GC: Radioprotection and radiosensitization by curcumin. Adv Exp Med Biol 2007;595:301-320.
10. Kunnumakkara AB, Diagaradjane P, Guha S, Deorukhkar A, Shentu S, Aggarwal BB, Krishnan S: Curcumin sensitizes human colorectal cancer xenografts in nude mice to gamma-radiation by targeting nuclear factor-kappaB-regulated gene products. Clin Cancer Res 2008;14:2128-2136.
11. Khafif A, Lev-Ari S, Vexler A, Barnea I, Starr A, Karaush V, Haif S, Ben-Yosef R: Curcumin: A potential radio-enhancer in head and neck cancer. Laryngoscope 2009;119:2019-2026.
12. Huang HC, Lin CL, Lin JK: 1, 2, 3, 4, 6-Penta-O-galloyl-β-D-glucose, quercetin, curcumin and lycopene induce cell-cycle arrest in MDA-MB-231 and BT474 cells through downregulation of skp2 protein. J Agric Food Chem 2011;59:6765-6775.
13. Shao J, Zheng D, Jiang Z, Xu H, Hu Y, Li X, Lu X: Curcumin delivery by methoxy polyethylene glycol-poly(caprolactone) nanoparticles inhibits the growth of C6 glioma cells. Acta biochimica et biophysica Sinica 2011;43:267-274.
14. MacCorkle RA, Tan TH: Mitogen-activated protein kinases in cell-cycle control. Cell Biochem Biophys 2005;43:451-461.
15. Rohan PJ, Davis P, Moskaluk CA, Kearns M, Krutzsch H, Siebenlist U, Kelly K: PAC-1: A mitogen-induced nuclear protein tyrosine phosphatase. Science 1993;259:1763-1766.
16. Bruick RK, McKnight SL: A conserved family of prolyl-4-hydroxylases that modify HIF. Science 2001;294:1337-1340.
17. Lin SC, Chien CW, Lee JC, Yeh YC, Hsu KF, Lai YY, Lin SC, Tsai SJ: Suppression of dual-specificity phosphatase-2 by hypoxia increases chemoresistance and malignancy in human cancer cells. J Clin Invest 2011;121:1905-1916.
18. Kvols LK: Radiation sensitizers: A selective review of molecules targeting DNA and non-DNA targets. J Nucl Med 2005;46 Suppl 1:187S-190S.
19. McKenna FW, Ahmad S: Fitting techniques of cell survival curves in high-dose region for use in stereotactic body radiation therapy. Phys Med Biol 2009;54:1593-1608.
20. Leonard CE, Chan DC, Chou TC, Kumar R, Bunn PA: Paclitaxel enhances in vitro radiosensitivity of squamous carcinoma cell lines of the head and neck. Cancer Res 1996;56:5198-5204.
21. Chendil D, Ranga RS, Meigooni D, Sathishkumar S, Ahmed MM: Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3. Oncogene 2004;23:1599-1607.
22. Bjork-Eriksson T, West C, Karlsson E, Mercke C: Tumor radiosensitivity (SF2) is a prognostic factor for local control in head and neck cancers. Int J Radiat Oncol Biol Phys 2000;46:13-19.
23. Shah MA, Schwartz GK: Cell cycle-mediated drug resistance: An emerging concept in cancer therapy. Clin Cancer Res 2001;7:2168-2181.
24. Simoens C, Vermorken JB, Korst AEC, Pauwels B, De Pooter CMJ, Pattyn GGO, Lambrechts HAJ, Breillout F, Lardon F: Cell cycle effects of vinflunine, the most recent promising vinca alkaloid, and its interaction with radiation, in vitro. Cancer Chemother Pharmacol 2006;58:210-218.
25. Harrison L, Blackwell K: Hypoxia and anemia: Factors in decreased sensitivity to radiation therapy and chemotherapy? Oncologist 2004;9:31-40.
26. Yang CW, Chang CL, Lee HC, Chi CW, Pan JP, Yang WC: Curcumin induces the apoptosis of human monocytic leukemia THP-1 cells via the activation of JNK/ERK pathways. BMC Complement Altern Med 2012;12:22.
27. Zhang B, Gu Y: Low expression of ERK signaling pathway affecting proliferation, cell cycle arrest and apoptosis of human gastric HGC-27 cells line. Mol Biol Rep 2014;41:3659-3669.
28. Gerhardt D, Bertola G, Dietrich F, Figueiro F, Zanotto-Filho A, Moreira Fonseca JC, Morrone FB, Barrios CH, Battastini AM, Salbego CG: Boldine induces cell cycle arrest and apoptosis in T24 human bladder cancer cell line via regulation of ERK, AKT, and GSK-3β. Urol Oncol 2014;32:36 e31-39.